Idiopathic dilated cardiomyopathy in the young: Clinical profile and natural history  by Taliercio, Charles P. et al.
1126 
PEDIATRIC CARDIOLOGY 
JACC Vol. 6, No, 5 
November 1985:1126-31 
Idiopathic Dilated Cardiomyopathy in the Young: Clinical Profile and 
Natural History 
CHARLES P, TALIERCIO, MD, JAMES B. SEWARD, MD, FACC, DAVID J. DRISCOLL, MD, FACC, 
LLOYD D. FISHER, PHD, FACC, BERNARD J. GERSH, MBCHB, DPHIL, FACC, 
ABDUL J. TAJIK, MD, FACC 
Rochester, Minnesota 
The clinical pro~le and course of documented cases of 
idiopathiC dilated cardiomyopathy in children have been 
poorly characterized. Twenty-four pati~nts (median age 
2 years, range < 1 month to 18 years) with idiopathic 
dilated cardiomyopathy were identified from Mayo Clinic 
records from 1973 to 1982. The most common pr~sen­
tation was congestive heart failure (92% of patients). 
Echocardiography (22 patients) generally revealed a di•
lated left ventricle with re,duced fractional shortening 
(inean 14%) and ejection fractlon (mean 26%); Two•
dimensional echocardiographic evidence of left ventric•
ular thrombus was present in 3 (23%) of 13 patients. 
Median cardiac index and left ventricular end-diastolic 
pressure (19 patients) were 2,5 iiters/min per m2 and 22 
mm Hg, respectively. Myocardial biopsy in eight pa•
tients showed nonspecific findilJ.gs without active inflam•
mation or evidence of endocardial fibroelastosis. 
On follow-up (rhean duration 33 months, range 0 to 
149), systemic arterial emboiism had occurred in 2 (8%) 
The cljnical characteristics and natural history of adults with 
idiopathic dilated cardioinyopathy are well described (1-3). 
Few reports (4-9) have focused on idiopathic dilated car•
diomyopattiy in patients younger than 20 years of age. The 
purpose of this report is to determine the natural history and 
predictors of death and survival in children with idiopathic 
dilated cardiomyopathy. 
Methods 
Patient selection. Mayo Clinic records from January 
1973 to December 1982 (i 0 years) were reviewed to identify 
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of 24 patients. Fifteen of 24 patients had died (63% 
survival at 1 year and 34 % survival at 5 years of follow•
up). The cause of death was congestive heart failure in 
11, complications after cardiac transplantation in 3 and 
sudden cardiac death in 1. Nine patients are alive at a 
mean follow-up time of 65 months (range 26 to 149); five 
are asymptomatic. Serial determination of left ventric•
uhir systolic function, available in all survivors, showed 
improvement in six patients and no significant change 
in three. Severe mitral inshfficiency Was present only in 
patients who ultimately died. A recent viral syndrome 
was noted more frequently .in patients who survived. 
There were no clinical or laboratory variables that were 
sensitive and specific predictors of outcome. Although 
the prognosis of idiopathic dilated cardiomyopathy in 
children is usuaily grave, a minority show unpredictable 
clinical improvement. 
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cases of idiopathic dilated cardiotnyopathy in patients youn•
ger than 20 years of age at the time of presentation to ttie 
Mayo Clinic or related hospitals. All patients with clinical 
or laboratory evidence of left ventricular dysfunction of 
uncertain origin were assessed in detail. Myocardial dys•
function due to congenital cardiac lesions, valvular defects 
or suspected or iderttified metabolic or toxic causes were 
excluded. Patients with transient clinical and cardiac ab•
normalities consistent with myocarditis were excluded. 
The medical history of the 24 selected patients was re•
viewed to determine age at onset of symptoms, symptoms, 
physical findings, clinical course, laboratory studies (chest 
X-ray film, electrocardiogram, echocardiogram and cardiac 
catheterization), treatment and outcome. Follow-up was by 
repeated examinations at the Mayo Clinic or letters from 
the patient's personal physician. The most recent appraisal 
of functional status included conversation by telephone with 
the patient's family or personal physician in five patients 
not followed up at the Mayo Clinic. 
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Analysis of data. The variables analyzed in each patient 
for association with survival were sex, age at onset, recent 
viral syndrome, cardiothoracic ratio on chest X-ray film, 
electrocardiographic variables (left ventricular hypertrophy, 
ST -T wave abnormalities and ventricular arrhythmias), 
echocardiographic variables (fractional shortening, ejection 
fraction, left atrial size and left ventricular thrombus) and 
cardiac catheterization variables (left ventricular end-dia•
stolic pressure, cardiac index and presence of severe mitral 
regurgitation), The echocardiographic ejection fraction was 
calculated using a modified method of Quinones et ai, (10), 
The univariate statistical significance of variables analyzed 
for prediction of survival was judged by the log-rank test 
for life tables for discrete variables and the Cox proportional 
hazards model for continuous variables. Survival was es•
timated by the product limit (Kaplan-Meier) method. 
Results 
Demographic profile and presentation of study pa•
tients. We identified 24 patients younger than 20 years of 
age with a diagnosis of idiopathic dilated cardiomyopathy; 
Table 1. Patient Demographics, Outcome and Clinical Data 
Mayo Clinic 
Age at Follow-up 
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11 were male and 13 were female. Relevant clinical data 
for each case are shown in Tables 1 and 2. The median age 
was 2 years (range < I month to 18 years) at the time of 
onset of symptoms. Twenty-two (92%) of 24 patients pre•
sented with clinical features of congestive heart failure as 
their initial manifestation. The two exceptions included one 
patient (Case 24) with a ventricular arrhythmia and another 
(Case 17) with asymptomatic cardiomegaly (cardiothoracic 
ratio 0.57). Thirteen patients had onset of symptoms of 
congestive heart failure within 3 months of symptoms of a 
presumed "viral" syndrome (that is, a nonspecific, acute 
febrile illness). 
Laboratory profile. At presentation, there was radio•
graphic evidence of definite cardiomegaly in 23 patients 
(cardiothoracic ratio> 0.55) and borderline cardiomegaly 
in 1 (Table 1). Mean cardiothoracic ratio was 0.64 (range 
0.49 to 0.86). Electrocardiograms showed normal sinus 
rhythm or sinus tachycardia in all patients, left ventricular 
hypertrophy by the Romhilt criteria (11) in 15 (63%) and 
ST-T wave abnormalities in 16 (68%). Bedside electrocar•
diographic monitoring demon3trated frequent multiform 
ventricular premature complexes in six patients. Holter 
monitoring was not routine and only obtained in two pa-
Prior 
Electrocardiogram 
"Viral" CXR(CT ST-T Ventricular 
Case Sex Onset (mo) Outcome Syndrome ratio) LVH Abnormaliti~s Arrhythmia 
I M <I mo Died D,Au 0.86 + 
2 M 12 !flo 5 D 0.62 + + 
3 F 18 yr 7 D,Au 0.67 + + 
4 M 18 yr 13 D,T,Au 0.62 + + 
5 F II mo Died D,Au 0.58 
6 M 10 yr 20 D,Au 0.68 + + 
7 F 15 yr 13 D 0.59 + + + 
8 F 17 mo 2 D + Q.66 + + + 
9 M 18 yr 3 D + 0.67 + + 
10 F 7 yr 2 D + 0.64 + 
11 M 2 yr 37 D + 0.59 + 
12 F 16 yr 5 D + 0.64 + + 
13 F 14 yr 50 D + 0.56 + 
14 F \0 yr 10 D,T 0.72 + + 
15 M 13 yr 25 D,T 0.57 + + 
16 M 3 mo 48 A 0.70 + + 
17 M <I mo 40 A,a 0.57 + 
18 F <I mo 95 A + 0.68 + 
19 M 3 mo 78 A,a + 0.63 
20 F 17 mo 149 A,a + 0.69 + + 
21 M 2 mo 25 A + 0.67 + + + 
22 F 3 mo 73 A,a + 0.(\5 + 
23 F <I mo 55 A,a + 0.70 
24 F 17 yr 26 A + 0.49 + 
A = alive; a = asymptomatic; Au = autopsy reviewed at Mayo Clinic; CT = cardiothoracic; CXR = chest X-ray film; D = dead; F = female; 
LVH = left ventricular hypertrophy; M = male; T = cardiac transplant patient. 
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tients. Electrophysiologic testing in four patients with ven•
tricular ectopic rhythm demonstrated sustained ventricular 
tachycardia (> 30 seconds in duration or requiring car•
dioversion) in three (Cases 6, 7 and 15) and nonsustained 
ventricular tachycardia « 30 seconds in duration) in one 
(Case 24). 
Echocardlograms (M-mode in 20, two-dimensional in 
13) were obtained in 22 patients (Table 2). All echocardio•
grams demonstrated depressed or borderline systoliC func•
tion (that is, fractional shortening and ejection fraction). 
Mean fractional shortening was 14% (range 3 to 30%, nor•
mal 31 to 45%) and ejection fraction was 26% (range 5 to 
51 %, normal 2:: 55%). Left atrial enlargement was noted in 
13 (54%). of 22 patients. Two-dimensional echocardio•
graphic studies (13 patients) or left ventricular angiograms 
(15 patients) at presentation demonstrated global left ven•
tricular dysfunction without major regional wall abnormal•
ities. Two-dimensional echocardiography showed evidence 
of intracavitary thrombus in 3 (23%) of 13 patients. 
Cardiac catheterization was performed in 16 patients at 
Table 2. Echocardiographic and Cardiac Catheterization Data 
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presentation and in 3 patients at 6 (Case 4), 15 (Case 14) 
and 29 (Case 20) months after presentation (Table 2). No 
patient had evidence of anomalous coronary arteries. Hemo•
dynamic data showed a median left ventricular end-diastolic 
pressure of 22 mm Hg (range 8 to 34) and median cardiac 
index of 2.5 liters/min per m2 (range 1.2 to 4.4). Three 
patients had severe mitral insufficiency. There were no 
structural abnormalities of the mitral valve noted on angi•
ography or echocardiography in these three. Right ventric•
ular biopsy in eight patients demonstrated nonspecific ab•
normalities without active inflammation. 
Tberapy. Treatment included digoxin in 22 patients, 
diuretic drugs in 16, antiarrhythmic agents in 5 and anti•
coagulant agents in 4; no patient received immunosuppres•
sive therapy. One patient (Case 21) had a small patent ductus 
arteriosus surgically dividied. 
Follow-up and survival. All patients were followed up 
for a mean period of 33 mortths (range 0 to 149). Two 
patients had a documented arterial embolus. Neither was on 
anticoagulant therapy at the time of the arterial embolism. 
Initial Echocardiogram Follow-up Echocardiogram Catheterization Data 
Months 
After 
LVOD LVSO FS EF LVOD FS EF First LVEDP CI Severe Cardiac 
Case (mm)* (mm) (%) (%) LAE LVTh (mm) (%) (%) Study (mmHg) (liters/min per m2) MR Biopsy 
I 20 + 
2 72(32) 54 25 44 + 29 2.3 
3 80(52) 65 19 34 + 27 1.2 + 
4 73(52) 66 10 18 + 32 2.7 + 
5 
6 35(45) 30 14 27 8 3.7 + 
7 75(52) 68 9 18 + 
8 50(38) 45 10 19 + + 
9 73(52) 71 3 5 + + 26 2.4 
10 42(45) 38 10 18 34 2.5 + 
11 65(38) 54 17 31 + 17 3.4 
12 68(52) 60 12 22 + 24 2.1 
13 52(52) 46 12 22 28 1.9 
14 64(52) 59 8 15 + 22 2.3 
15 37(32) 26 30 51 + + 14 2.1 + 
16 27(32) 24 11 21 55 18 33 48 25 3.1 
17 35(32) 29 17 31 40 18 32 40 16 4.4 + 
18 27(32) 20 26 45 + 57 26 46 94 22 2.8 + 
19 36(32) 34 6 II 71t 15 12 4.1 
20 47(36) 38 19 35 45t 111 27 2.4 
21 43(32) 41 5 9 + + 46 22 39 25 16 2.8 + 
22 31(32) 28 10 18 + 46 20 35 25 
23 46(32) 40 13 24 + 46 26 45 43 22 
24 58(52) 43 26 45 58 31 52 25 + 
*Maximal normal dimensions for age in parentheses; tejection fraction (EF) obtained by ventriculography; :j:ejection fraction obtained by radionuclide 
angiography. At follow-up, Cases 1 to 15 are dead and Cases 16 to 24 are alive. CI = cardiac index; FS = fractional shortening; LAE = left atrial 
enlargement; L VDD = left ventricular diastolic diameter; L VEDP = left ventricular end-diastolic pressure; L VSD = left ventricular systolic diameter; 
LV Th = left ventricular thrombus; MR = mitral regurgitation. 
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One of the patients (Case 11) experienced sudden left hemi•
paresis with gradual resolution and the second (Case 13) 
developed unilateral visual loss with subsequent improve•
ment. Both were treated with anticoagulant agents with no 
further embolic episodes, Two-dimensional echocardio•
graphic examinations to search for intracavitary thrombus 
were not performed at the time of the neurologic symptoms, 
Fifteen patients (63%) died, The cumulative survival rate 
(Fig, 1) was 63% at 1 year, 50% at 2 years and 34% at 5 
years of follow-up, The cause of death was intractable 
congestive heart failure in II, sudden death presumably 
secondary to a ventricular arrhythmia in 1 and death at or 
in the immediate postoperative period of cardiac transplan•
tation in 3. Autopsy data were reviewed at the Mayo Clinic 
in five patients and all had a dilated heart without specific 
etiologic features. 
Nine patients are alive and five of these are asympto•
matic. The average duration of follow-up for the survivors 
is 65 months (range 26 to 149). Four asymptomatic patients 
(Cases 19, 20, 22 and 23) previously had symptoms of 
congestive heart failure; one patient (Case 17) presented 
with asymptomatic cardiomegaly. In the former four pa•
tients, symptoms disappeared 3 to 24 months after presen•
tation. In two of these patients (Cases 19 and 20), chest X•
ray film showed that cardiomegaly had resolved. Follow•
up assessment of left ventricular function, available in all 
survivors (echocardiography in seven, exercise radionuclide 
angiography in one and left ventriculography at cardiac cath•
eterization in one), showed normal left ventricular function 
in one, improved (210% increase in ejection fraction) but 
abnormal left ventricular function in five and no significant 
change in three (Table 2). There was no evidence of left 
ventricular thrombus on follow-up two-dimensional echo•
cardiography in seven patients. Three patients (Cases 16, 
18 and 21) are in stable condition with New York Heart 
Association functional class II to III symptoms. One patient 
(Case 24) remains on treatment for ventricular arrhythmias 
without symptoms of congestive heart failure. 
Figure 1. Survival curve in 24 cases. 
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Predictors of survival. There were only two clinical or 
laboratory variables that demonstrated significant univariate 
association with death or survival. Severe mitral regurgi•
tation by angiography was noted only in three patients who 
eventually died (p = 0.002), and can be regarded as an 
insensitive but specific predictor of poor outcome. Viral 
symptoms within 3 months of presentation occurred more 
frequently in patients who survived. The difference reached 
modest statistical significance (p < 0.04). The analysis also 
suggested that survival was worse in older patients but the 
difference was not statistically significant (p = 0.08). No 
other clinical or laboratory variables predicted survival. A v•
erage cardiothoracic ratio in survivors versus nonsurvivors 
was almost identical (0.65 versus 0.64, respectively). 
Electrocardiographic evidence of left ventricular hypertro•
phy, ST -T wave abnormalities and ventricular arrhythmias 
occurred equally in both groups. Echocardiographic indexes 
of left ventricular function in survivors and non survivors 
were nearly identical. Mean fractional shortening was 14% 
in nonsurvivors and 15% in survivors. Left atrial enlarge•
ment measured by echocardiogram was somewhat more 
common in patients who ultimately died, but the difference 
was not significant. Left ventricular end-diastolic pressure 
and cardiac index as derived from cardiac catheterization 
were similar in the two groups. 
Discussion 
Prior reports. Greenwood et al. (4) reviewed 161 pe•
diatric patients with "primary myocardial disease" seen at 
a Boston medical center from 1945 to 1974 and followed 
up for a mean period of 41 months. They reported that 
approximately one-third died, one-third recovered and one•
third had chronic symptoms. This preechocardiographic study 
utilized cardiac catheterization in a small number of patients 
and included patients with diagnoses of endocardial fibro•
elastosis, myocarditis and restrictive cardiomyopathy. Ma•
ron and Roberts (5) discussed idiopathic dilated cardio•
myopathy in a review of cardiomyopathy in the first two 
decades of life, but concentrated on pathologic features with 
little discussion of other clinical data, including prognosis. 
The report of Doshi and Lodge (6) of nine patients with 
idiopathic dilated cardiomyopathy also described a patho•
logic series. Harris et al. (7) reported on eight patients with 
a dilated form of idiopathic nonobstructive cardiomyopathy. 
Follow-up study revealed death in five patients with two 
patients becoming asymptomatic. Van Der Hauwaert et al. 
(9) recently reported echocardiographic findings in patients 
who survived at least 2 years after presenting with conges•
tive heart failure, left ventricular hypertrophy and cardio•
megaly of uncertain origin before the age of 18 months. 
Follow-up data were available in 32 patients originally iden•
tified and revealed 12 deaths (mortality rate 38%) at 4.5 to 
7 years follow-up. 
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Characterization of study group. In this study, we ex•
amined the clinical characteristics and outcome of a group 
of pediatric patients with dilated cardiomyopathy of uncer•
tain origin. Twenty-four patients aged less than I month to 
18 years were identified. Clinical diagnoses were confirmed 
by echocardiography, cardiac catheterization data or au•
topsy. Patients with known endocardial fibroelastosis, my•
ocarditis or myocardial dysfunction as a result of known 
causes were not included. Twelve patients did present at 
less than 2 years of age and seven of these had electrocar•
diographic evidence of left ventricular hypertrophy. A di•
lated form of endocardial fibroelastosis could not be ruled 
out with certainty in this latter group. Three of these patients 
had myocardial biopsy with no evidence of endocardial fi•
broelastosis. Approximately half (13 of 24) of our patients 
had the onset of symptoms in close proximity to a nonspe•
cific illness ascribed to a viral syndrome, and this raises the 
possibility of acute myocarditis as the original pathophy•
siologic mechanism in these patients. Myocardial biopsy in 
six of these patients showed no evidence of active myo•
carditis. Coxsackie B titers were not obtained. 
Outcome and predictors of survival. Follow-up dem•
onstrated a grave prognosis in this patient group with 63% 
survival at I year and 34% survival at 5 years (Fig. I). 
Fuster et al. (1) reported a comparable survival rate of 37% 
at 5 years' follow-up in adult patients with idiopathic dilated 
cardiomyopathy. Intractable congestive heart failure was the 
most frequent cause of death in our series. Congestive heart 
failure is commonly the cause of death in adults with idio•
pathic dilated cardiomyopathy, although a recent study (12) 
reported a 50% incidence of sudden death. 
Whether an individual patient's ultimate outcome is de•
pendent on differences in the severity or progression of the 
disease process, differences in host adaptation or other fac•
tors is speculative. The clinical data at presentation did not 
enable us to adequately predict a patient's clinical course. 
Severe mitral insufficiency at angiography was observed 
only in three patients who ultimately died. This variable 
was insensitive in predicting poor outcome. Recent viral 
symptoms were noted more frequently in survivors; this 
finding had modest statistical significance, and its impor•
tance is questionable. A febrile, respiratory illness may stress 
an abnormal but previously compensated heart and produce 
cardiac symptoms. Recent viral symptoms may also identify 
some patients who have developed cardiomyopathy related 
to myocarditis. The outcome of infants with definite acute 
myocarditis is generally not favorable (13). The frequency 
of mild or asymptomatic myocarditis in infants and children 
is unknown and conceivably may have been the original 
cardiac lesion in some of our patients. As a predictor of 
survival, the variable of recent viral symptoms was 78% 
sensitive and 60% specific. These indexes are of limited 
clinical value. 
Both survivors and nonsurvivors had similar degrees of 
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cardiomegaly on chest X-ray film and electrocardiographic 
abnormalities. Electrocardiographic evidence of left ven•
tricular hypertrophy in one study (14) of adult patients with 
dilated cardiomyopathy appeared to identify a group with 
longer survival. In our study, 5 year survival in groups with 
and without electrocardiographic evidence of left ventricular 
hypertrophy was identical (34%). Thus, there was no ap•
parent benefit with regard to survival from the presence of 
electrocardiographic evidence of left ventricular hypertrophy. 
Adults with idiopathic dilated cardiomyopathy who have 
very poor ventricular function and marked hemodynamic 
abnormalities usually fare poorly (1). Initial echocardio•
graphic variables of systolic function (fractional shortening 
and ejection fraction) as well as hemodynamic data derived 
from cardiac catheterization were not different in survivors 
and nonsurvivors in our series. 
Left ventricular thrombus and arterial emboliza•
tion. Three (23%) of 13 patients with two-dimensional 
echocardiographic examinations had evidence of intracav•
itary thrombus. Two other patients (8%) had definite arterial 
embolization. Transient abnormalities related to arterial em•
bolization may have occurred in some of the younger pa•
tients but was undetected because these patients are usually 
poor historians. Other investigations (1,8,15) in adults and 
children with dilated cardiomyopathy have reported an in•
cidence of arterial embolization ranging from 17 to 38%. 
Anticoagulant therapy in adults with idiopathic dilated car•
diomyopathy decreases the incidence of arterial emboliza•
tion (1). Anticoagulant therapy in children with idiopathic 
dilated cardiomyopathy should be considered in the presence 
of severely depressed left ventricular function. 
Conclusion. Idiopathic dilated cardiomyopathy in the 
young has a poor prognosis when the patient presents with 
congestive heart failure. Some patients survive and show 
improvement, but the clinical indexes examined in this study 
showed no good predictors of survival. Whether more so•
phisticated and recently developed techniques can identify 
predictors of survival is unknown. Patients who became 
asymptomatic during the follow-up period did so 3 to 24 
months after presentation. A longer follow-up time will be 
necessary to see if these patients remain symptom-free. 
We appreciate the follow-up data supplied by Guy Carter, MD, Howard 
Palay, MD, John Curtis, MD and Herbert D. Ruttenberg, MD. 
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